Capital Management Corp VA Raises Stock Holdings in Lifevantage Corporation (NASDAQ:LFVN)

Capital Management Corp VA raised its position in Lifevantage Corporation (NASDAQ:LFVN - Free Report) by 137.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 715,503 shares of the company's stock after acquiring an additional 413,918 shares during the quarter. Lifevantage makes up 1.8% of Capital Management Corp VA's investment portfolio, making the stock its 25th largest position. Capital Management Corp VA owned 5.70% of Lifevantage worth $10,432,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the company. Bank of New York Mellon Corp increased its holdings in Lifevantage by 43.9% during the 4th quarter. Bank of New York Mellon Corp now owns 74,183 shares of the company's stock valued at $1,300,000 after purchasing an additional 22,620 shares during the period. American Century Companies Inc. increased its holdings in Lifevantage by 50.5% during the 4th quarter. American Century Companies Inc. now owns 95,552 shares of the company's stock valued at $1,675,000 after purchasing an additional 32,055 shares during the period. Hillsdale Investment Management Inc. increased its holdings in Lifevantage by 7.3% during the 4th quarter. Hillsdale Investment Management Inc. now owns 14,720 shares of the company's stock valued at $258,000 after purchasing an additional 1,000 shares during the period. LPL Financial LLC increased its holdings in Lifevantage by 301.0% during the 4th quarter. LPL Financial LLC now owns 211,039 shares of the company's stock valued at $3,700,000 after purchasing an additional 158,405 shares during the period. Finally, O Shaughnessy Asset Management LLC lifted its holdings in Lifevantage by 56.2% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 93,576 shares of the company's stock worth $1,640,000 after buying an additional 33,658 shares during the period. Hedge funds and other institutional investors own 35.32% of the company's stock.

Insider Activity

In other news, CFO Carl Aure sold 2,746 shares of the firm's stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $13.39, for a total value of $36,768.94. Following the transaction, the chief financial officer directly owned 133,303 shares in the company, valued at $1,784,927.17. This trade represents a 2.02% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. 20.65% of the stock is currently owned by insiders.

Lifevantage Stock Down 2.4%

Shares of NASDAQ:LFVN traded down $0.32 during trading on Monday, hitting $12.66. The stock had a trading volume of 24,057 shares, compared to its average volume of 210,976. Lifevantage Corporation has a 12 month low of $6.43 and a 12 month high of $27.38. The company has a market capitalization of $159.33 million, a PE ratio of 18.34 and a beta of 0.43. The firm's fifty day moving average is $12.75 and its 200 day moving average is $15.58.

Lifevantage (NASDAQ:LFVN - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.10. The company had revenue of $58.44 million for the quarter, compared to the consensus estimate of $60.99 million. Lifevantage had a return on equity of 34.67% and a net margin of 4.12%.

Lifevantage Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, June 13th. Stockholders of record on Friday, May 30th were issued a dividend of $0.045 per share. This is an increase from Lifevantage's previous quarterly dividend of $0.04. This represents a $0.18 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date was Friday, May 30th. Lifevantage's dividend payout ratio is presently 26.09%.

Lifevantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.